IRIDEX Corporation (IRIX)
1.02
-0.01 (-0.97%)
At close: Apr 17, 2025, 3:58 PM
1.02
-0.18%
After-hours: Apr 17, 2025, 07:17 PM EDT
-0.97% (1D)
| Bid | 1.01 |
| Market Cap | 17.12M |
| Revenue (ttm) | 48.67M |
| Net Income (ttm) | -8.91M |
| EPS (ttm) | -0.54 |
| PE Ratio (ttm) | -1.89 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 1.03 |
| Volume | 105,689 |
| Avg. Volume (20D) | 75,516 |
| Open | 1.02 |
| Previous Close | 1.03 |
| Day's Range | 0.98 - 1.04 |
| 52-Week Range | 0.78 - 3.25 |
| Beta | 0.74 |
About IRIX
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuL...
Industry Medical - Devices
Sector Healthcare
IPO Date Feb 16, 1996
Employees 93
Stock Exchange NASDAQ
Ticker Symbol IRIX
Website https://www.iridex.com
Analyst Forecast
According to 1 analyst ratings, the average rating for IRIX stock is "Hold." The 12-month stock price forecast is $2, which is an increase of 96.08% from the latest price.
Stock Forecasts3 weeks ago
+13.15%
Iridex shares are trading higher after the company...
Unlock content with
Pro Subscription
5 months ago
+34.04%
IRIDEX shares are trading higher. The company reported Q3 financial results.
